new and emerging agents in her2-negative metastatic breast cancer: implications for practice
Published 1 year ago • 2.9K plays • Length 34:12Download video MP4
Download video MP3
Similar videos
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
34:06
the emerging role of serd's in hr breast cancer
-
34:21
expanding options for her2 advanced breast cancer: taking trial data to the clinic
-
35:36
personalized treatment of advanced her2-negative gastric or gastroesophageal junction cancer
-
40:56
new horizons in high-risk hr her2- ebc: risk stratification for early identification
-
6:55
mafalda oliveira, sabcs 2022: camizestrant vs fulvestrant for advanced er her2- breast cancer
-
2:02
what treatments are available for her2-positive metastatic breast cancer?
-
9:53
fibrosis biomarker: can it 🧬 predict survival rates in her2-negative breast cancer? 🎗️
-
33:28
novel targeted therapies for nsclc: exploring her2 dysregulation
-
1:24
dr. yardley on emerging agents in her2-positive breast cancer
-
1:39
treatment for her2 metastatic breast cancer
-
47:29
how can her2-targeted therapies be incorporated into the management of patients with crc?
-
6:09
emerging agents for her2 mbc: targeted therapeutics
-
34:33
expert exchange: clinical implications of the latest advances in metastatic breast cancer
-
6:21
emerging agents for her2 mbc: her2climb and sophia trials
-
1:55
dr. hurvitz on novel emerging agents in her2 breast cancer
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
1:13
overall survival data of the monarch-2 trial in hr /her2- breast cancer
-
2:05
latest news in her2-low breast cancer